ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
87.39
+0.05 (+0.06%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close87.34
Open87.48
Bid86.95 x 900
Ask89.00 x 1300
Day's range86.77 - 87.65
52-week range55.80 - 87.69
Volume2,764,440
Avg. volume3,652,975
Market cap49.133B
Beta1.12
PE ratio (TTM)10.64
EPS (TTM)8.21
Earnings date22 Oct 2018 - 26 Oct 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend date2003-11-12
1y target est85.94
Trade prices are not sourced from all markets
  • The Wall Street Journal2 days ago

    [$$] Are Pharmacy Startups Ready to Take on Role as Disrupters?

    Startups have infused the pharmacy business with a dose of modern technology, and it’s resonating with consumers. In the past few years, companies like Capsule Corp., which just raised $50 million, Sequoia-backed NimbleRx Inc., and NowRx Inc. have all reported ongoing customer growth, owing to consumer-focused modern conveniences like app-based delivery orders and transparent pricing. “These deals like PillPack and GoodRx are idiosyncratic,” said Venrock Partner Bob Kocher, whose firm hasn’t backed any pharmacy startups to date.

  • Focus: Express Scripts staking out million-dollar gene therapies
    Reuters3 days ago

    Focus: Express Scripts staking out million-dollar gene therapies

    Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. Express Scripts is in talks with biotechnology companies Biomarin Pharmaceutical Inc, Spark Therapeutics Inc and Bluebird Bio Inc to have its specialty pharmaceutical business exclusively distribute their new hemophilia therapies when they are expected to become available in 2019 and 2020, Chief Medical Officer Steve Miller told Reuters in an interview.

  • Associated Press3 days ago

    Tapestry, Advance Auto Parts and Wolverine rise

    Stocks that moved substantially or added heavily on Tuesday: Tapestry Inc., up $5.70 to $53.16 The shoe and handbag maker had a stronger fourth quarter than analysts expected. Advance Auto Parts Inc., ...

  • Icahn drops objection, Nvidia unveils new tech, McDonald’s to get a facelift
    Yahoo Finance4 days ago

    Icahn drops objection, Nvidia unveils new tech, McDonald’s to get a facelift

    Cigna, Express Scripts, Nvidia, McDonald’s and Twitter are the companies to watch.

  • The Wall Street Journal4 days ago

    [$$] Stocks to Watch: Tesla, Home Depot, Switch, Express Scripts, Ford

    Here are some of the companies with shares expected to trade actively in Tuesday’s session. Stock movements reflect premarket trading. Tesla Inc.—Up 0.3%: Tesla announced the formation of a special committee to evaluate the company’s potential move to go private, which Chief Executive Elon Musk tweeted about last week.

  • Options Traders Expect Huge Moves in Express Scripts (ESRX) Stock
    Zacks4 days ago

    Options Traders Expect Huge Moves in Express Scripts (ESRX) Stock

    Express Scripts (ESRX) needs investors to pay close attention to the stock based on moves in the options market lately.

  • Icahn ends Cigna-Express Scripts campaign, shares bounce
    Associated Press4 days ago

    Icahn ends Cigna-Express Scripts campaign, shares bounce

    Shares of Express Scripts are moving higher before the opening bell after activist investor Carl Icahn ended a short-lived fight to scuttle Cigna's takeover of the pharmacy benefit manager. Icahn said late Monday that he'll end his campaign to convince Cigna shareholders to vote against the roughly $52-billion deal this month. Icahn argued in a lengthy letter to fellow shareholders last week that Cigna was "dramatically overpaying" for Express Scripts.

  • Financial Times4 days ago

    [$$] Carl Icahn backs down over opposition to Cigna-Express Scripts deal

    to Cigna’s $67bn acquisition of Express Scripts, only a week after launching a withering attack that branded the deal “inexplicably ridiculous”. Mr Icahn’s climbdown ahead of a shareholder vote on August 24 follows expressions of support for the deal from the influential proxy advisers ISS and Glass Lewis, as well as backing for the takeover from Larry Robbins’s Glenview Capital Management hedge fund. Previously short Express Scripts stock, Mr Icahn said last week that “the only shareholders we believe would vote for this very risky acquisition are those who also own Express Scripts and are desperate to save it even at the expense of losing a great deal of value in their Cigna investment”.

  • Financial Times4 days ago

    [$$] M&A/activists: Carl cools it

    Nothing is guaranteed to terrify a chief executive more than Carl Icahn tweeting about his or her company. It does not have to be that way. Last week Mr Icahn expressed his opposition to Cigna's pending ...

  • The Wall Street Journal4 days ago

    [$$] Icahn Backs Down on Cigna-Express Scripts Deal

    Carl Icahn no longer plans to solicit votes from Cigna Corp. shareholders against the health insurer’s $54 billion deal to buy Express Scripts Holding Co. after two proxy-advisory firms recommended shareholders support the deal, the billionaire activist investor said in a statement Monday. It called his opposition “misguided and shortsighted” in a statement last week.

  • Amazon Fined as It Plans to Expand in Italy
    Market Realist5 days ago

    Amazon Fined as It Plans to Expand in Italy

    On August 2, Italy’s communications regulator AGCOM fined Amazon (AMZN) 300,000 euros (~$350,000) for allegedly offering postal services without first obtaining proper authorization, Reuters reported.

  • The Wall Street Journal7 days ago

    [$$] ISS Backs Cigna-Express Scripts Deal, in Blow to Carl Icahn

    Carl Icahn’s effort to find enough allies to block Cigna Corp.’s $54 billion proposed purchase of pharmacy-benefit manager Express Scripts Holding Co. just got a little harder. Institutional Shareholder Services, one of two major proxy-advisory firms, is recommending shareholders of the health insurer and Express Scripts support the deal in a vote later this month, according to reports ISS clients received Friday that were viewed by The Wall Street Journal. The news sent shares of Express Scripts up 3.8% to $84.90 Friday morning, as the odds the takeover will be completed appeared to improve.

  • Associated Press7 days ago

    Citigroup and Caterpillar slide while Overstock rises

    Stocks that moved substantially or traded heavily Friday: Overstock.com Inc., up $3.05 to $41.65 The online discount retailer said a private equity firm is investing in its blockchain business. Citigroup ...

  • Associated Press7 days ago

    Key shareholder adviser backs Cigna-Express Scripts deal

    Cigna's plan to buy pharmacy benefit manager Express Scripts for around $52 billion has received a big endorsement a few days after activist investor Carl Icahn urged shareholders to reject it. The proxy ...

  • Associated Press7 days ago

    Key shareholder adviser backs Cigna-Express Scripts deal

    Cigna's plan to buy pharmacy benefit manager Express Scripts for around $52 billion has received a big endorsement a few days after activist investor Carl Icahn urged shareholders to reject it. The proxy ...

  • Here's how the proposed CVS-Aetna merger could increase costs, restrict access
    CNBC8 days ago

    Here's how the proposed CVS-Aetna merger could increase costs, restrict access

    While the U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS and Aetna, patients and physicians should do so at every turn, says Dr. Theresa Rohr-Kirchgraber.

  • Motley Fool8 days ago

    Carl Icahn Fires Shots at Express Scripts

    Billionaire activist-investor Carl Icahn thinks Cigna’s planned tie-up with Express Scripts is a big blunder.

  • Glenview's Larry Robbins takes on Carl Icahn, defends Cigna-Express Scripts deal
    CNBC9 days ago

    Glenview's Larry Robbins takes on Carl Icahn, defends Cigna-Express Scripts deal

    Glenview Capital's Larry Robbins is defending Cigna's deal to acquire Express Scripts.

  • Financial Times9 days ago

    [$$] Glenview backs Cigna-Express Scripts deal after Icahn blast

    Glenview, which said it has been invested in Cigna for a decade, told the US health insurer’s shareholders in a letter the agreed price is “cheap” for what it is getting. The hedge fund owns around $1.3bn across Cigna and Express Scripts, split roughly evenly between the two. “Sensationalist headlines and intentionally misleading assertions from those with conflicting interests and limited analysis should not carry more weight than balanced diligence,” Glenview wrote in the letter.

  • Barrons.com10 days ago

    A Top Cigna Executive Is the First Insider to Buy Up Stock Since 2015

    Cigna's (CI) chief financial officer, Eric Palmer, recently became the health insurer's first executive or director to buy the health insurer's shares on the open market since 2015. Palmer made the purchase through a Rule 10b5-1 trading plan that he adopted on May 29. The last open-market stock purchase by a Cigna insider was on Dec. 10, 2015, when director John M. Partridge bought 7,200 shares for his personal account and 1,620 shares through a trust.

  • Cigna CEO is 'disappointed' Carl Icahn shared his concerns about Express Scripts deal in open letter
    CNBC10 days ago

    Cigna CEO is 'disappointed' Carl Icahn shared his concerns about Express Scripts deal in open letter

    Icahn published a searing letter opposing Cigna's $54 billion acquisition of pharmacy benefit manager Express Scripts. Titled "Cigna's $60 billion folly," he says buying the firm "may well become one of the worst blunders in corporate history."

  • Asian shares mixed after new US tariffs put on China exports
    Associated Press10 days ago

    Asian shares mixed after new US tariffs put on China exports

    Shares were mostly higher in Asia on Wednesday after the U.S. followed through with plans to put higher tariffs on $16 billion in Chinese exports. KEEPING SCORE: Japan's Nikkei 225 index gained 0.4 percent ...

  • Why Carl Icahn Is Long Cigna and Short Express Scripts
    Motley Fool10 days ago

    Why Carl Icahn Is Long Cigna and Short Express Scripts

    The activist investor is lobbying shareholders to vote against their planned merger.

  • Icahn's opposition to Express Scripts merger is 'misguided and short-sighted,' Cigna says
    CNBC10 days ago

    Icahn's opposition to Express Scripts merger is 'misguided and short-sighted,' Cigna says

    Cigna defended the deal, saying it would "create tremendous value for shareholders, accelerate the transformation of healthcare and address the dynamic regulatory environment for health services."

  • The Wall Street Journal10 days ago

    [$$] Icahn Goes Public Against Cigna's Express Scripts Deal

    The billionaire activist investor sent an open letter Tuesday urging fellow Cigna shareholders to vote against the deal, which he calls a “$60 billion folly” carrying a “ridiculous” price tag. The Wall Street Journal reported on the forthcoming letter Monday. “Cigna is dramatically overpaying for a highly challenged Express Scripts that is facing existential risks on several fronts,” Mr. Icahn wrote.